glp-1 agonists for diabetes Targeting GLP-1, GIP & GCG in Obesity and Type 2 Research GLP-1 Receptor Agonists: A Game-Changer

Biological basis of cravings The hormone that these drugs mimic GLP-1 is not only produced in the gut

Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, et al

Therefore, this review aims to synthesize the evidence on the mechanistic expansion of GLP-1RAs from metabolic regulators to systemic modulators of inflammation, autophagy, and organ protection, and explores their therapeutic repurposing across diseases

A recent and more extensive ( N = 10,690 people with diabetes followed up over 67 years) historical cohort study observed a reduced association between GLP-1RA use compared with non-use for depressive and, more pronouncedly, anxiety disorders incidence, especially in women 32

SGLT-2 inhibitors and GLP-1RA should, therefore, be considered evidence-based treatments for patients with type 2 diabetes after metformin

Yoga, stretching, even pressing gently on your abdomen in a clockwise circle can relieve bloating and encourage motility